Search Results - anil+sood

2 Results

Sort By:

Antibodies against CD5L for therapeutic and diagnostic uses

Provided herein are anti-CD5L monoclonal antibodies. Further provided herein are methods of use thereof for the treatment of a disease or disorder, such as cancer. UTHealth Ref. No.: 2020-0016 Inventors: Dr. Zhiqiang An and Dr. Ningyan Zhang at UTHealth; Dr. Anil Sood at UT M.D. Anderson Cancer Center Patent Status: PCT application PCT/US2021/025429...

Published: 10/17/2024 | Inventor(s): Zhiqiang An, Ningyan Zhang, Anil Sood

Keywords(s):

Category(s): Biologics, Oncology, Therapeutics

EGFL6 Specific Monoclonal Antibodies for Cancer Diagnostic and Therapeutic Use

Human epidermal growth factor (EGF)-like domain multiple 6 (EGFL6) was discovered in tumors and fetal tissues. Upregulated expression of EGFL6 was found in a variety of cancer cell types, such as ovarian cancer and lung cancer. Unlike VEGF, which was expressed in ovarian cancer tissues and in healing wounds, EGFL6 was expressed mainly in tumor-associated...

Published: 10/17/2024 | Inventor(s): Zhiqiang An, Anil Sood, Ningyan Zhang

Keywords(s):

Category(s): Biologics, Therapeutics, Oncology